The clinical mortality rate of septicemia of premature infants is high. Coagulase-negative Staphylococcus and Staphylococcus aureus are the main pathogens of this disease, and vancomycin is the common treatment. The administration of premature infants should not only ensure the best efficacy, but also minimize nephrotoxicity and ototoxicity. At present, the guidelines of various countries have not reached consensus on the monitoring indicators of blood concentration of vancomycin in premature infants, the target range of indicators, and the initial administration plan. In this paper, the pharmacokinetic characteristics of vancomycin in premature infants, blood concentration monitoring indicators, target range of indicators, initial treatment plan, drug safety literature were reviewed, to provide some reference for clinical drug use.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |